menu search

NMRD / Nemaura Medical to Present at the Maxim Group 2022 Virtual Growth Conference

Nemaura Medical to Present at the Maxim Group 2022 Virtual Growth Conference
Loughborough, England, March 24, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and commercializing wearable diagnostic devices and supporting personalized lifestyle coaching programs, announces today that CEO Dr. Faz Chowdhury will participate at the Maxim Group 2022 Virtual Growth Conference, which is being held on March 28-30, 2022. Read More
Posted: Mar 24 2022, 16:24
Author Name: GlobeNewsWire
Views: 042011

NMRD News  

Nemaura Medical to Present at the Maxim Group Emerging Growth in A.I. Conference

By GlobeNewsWire
September 18, 2023

Nemaura Medical to Present at the Maxim Group Emerging Growth in A.I. Conference

Loughborough, England, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and more_horizontal

Nemaura Medical, Inc. (NMRD) Upgraded to Buy: What Does It Mean for the Stock?

By Zacks Investment Research
August 23, 2023

Nemaura Medical, Inc. (NMRD) Upgraded to Buy: What Does It Mean for the Stock?

Nemaura Medical, Inc. (NMRD) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This migh more_horizontal

Nemaura Medical to Participate in Fireside Chat at the MicroCap Rodeo Winter Wonderland Best Ideas 2023 Virtual Conference

By GlobeNewsWire
February 16, 2023

Nemaura Medical to Participate in Fireside Chat at the MicroCap Rodeo Winter Wonderland Best Ideas 2023 Virtual Conference

Loughborough, England, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and more_horizontal

Nemaura Medical to Present at the Maxim Group 2022 Virtual Growth Conference

By GlobeNewsWire
March 24, 2022

Nemaura Medical to Present at the Maxim Group 2022 Virtual Growth Conference

Loughborough, England, March 24, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing and more_horizontal

Nemaura Medical: Opportunity In The Consumer-Centered Continuous Glucose Monitoring Market

By Seeking Alpha
March 10, 2022

Nemaura Medical: Opportunity In The Consumer-Centered Continuous Glucose Monitoring Market

The Continuous Glucose Monitoring Market is expanding to consumer-centered CGM wellness devices, targeting Type-2 diabetics, prediabetics, and healthy more_horizontal


Search within

Pages Search Results: